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The development of emergency medical services and especially neurosurgical emergencies during recent decades has necessitated
the development of novel tools. Although the gadgets that the neurosurgeon uses today in emergencies give him important help
in diagnosis and treatment, we still need new technology, which has rapidly developed. This review presents the latest diagnostic
tools, which offer precious help in everyday emergency neurosurgery practice. New ultrasound devices make the diagnosis of
haematomas easier. In stroke, the introduction of noninvasive new gadgets aims to provide better treatment to the patient. Finally,
the entire development of computed tomography and progress in radiology have resulted in innovative CT scans and angiographic
devices that advance the diagnosis, treatment, and outcome of the patent. The pressure on physicians to be quick and effective and
to avoid any misjudgement of the patient has been transferred to the technology, with the emphasis on developing new systems
that will provide our patients with a better outcome and quality of life.
1. Introduction
When an emergency care systemmatures, the scope of emer-
gency medicine (EM) expands. Most emergency department
care is provided by specially trained physicians. There is a
mature academic professional organization that can advance
the field, which can now sustain fellowships and subspe-
cialization, national databases, and peer reviewed journals.
Emergency medical services systems are developed and run
on city, regional, and even national levels. Internationally, two
different systems have been developed for the delivery of
emergency medical care. The first is the Anglo-American
model that is familiar within the United States and the other
is the Franco-German model. The Anglo-American model
provides prehospital care. Paramedic and emergencymedical
technicians extend the role of the physician, caring for,
stabilizing, and transporting the patient. On the other hand,
in the Franco-German model, care is brought to the patient.
Emergency systems used to provide out-of-hospital urgent
care and to screen the patients to decide who needs to be
transferred. The physician and the technology are sent to the
scene in the hope of providing an immediate high level of care
when most needed. Management systems are currently in
place for process improvement, quality assurance, and cost
controls. Countries that can be described as having mature
emergency care systems include Australia, Canada, the
United Kingdom, Germany, Switzerland, and the United
States [1].
2. The Necessity of New
Technology: Telemedicine
Rapid assessment of injuries and life-preserving therapy is
required, but defining the optimal strategy can be compli-
cated when multiple organ systems are involved [2]. The
improvements needed in emergency neurosurgery can be
supported by introducing new tools for specialists.
Although the gadgets and tools that the neurosurgeon
uses today in emergencies give him important help ins
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diagnosing and treating the patient, we still need new
technology. This should accelerate diagnosis and treatment.
Moreover, it must be user-friendly, so that it can be used even
by a junior physician and still give excellent results. Further-
more, modern technology concentrates on avoiding misdi-
agnosis, as this can lead to disastrous results for the patient.
Additionally, rapid and specific diagnosis can always help to
improve the patient’s quality of life.
Another very important instrument that has to be devel-
oped for neurosurgical emergencies is the telemedical emer-
gency neurosurgical network. Teleeducation, teleconferenc-
ing, and teleconsultation have flourished, albeit mainly as a
showcase between a number of emergency units within
leading institutes [3, 4].
With advances in information and imaging technology,
the application of robotic systems to the health sector has
become a burgeoning field in assisting surgeons inmanipulat-
ing, monitoring, and/or guiding operations, with the advan-
tages of high targeting precision, reliable support during
protracted operations, and the possibility of preoperative
planning based on patients’ images. In 2001, around 270,000
image-guided robotic operations were conducted annually
worldwide [3, 4].
In the developing countries, telemedicine holds promises
increasingly balanced access to health care services. To this
end, collaboration with the developed countries will increase
and will help to ensure that expertise, knowledge, and expe-
rience are more rapidly and more cheaply available [3].
3. Novel Neurosurgical Tools
There have recently been rapid developments in medical
technology in emergency departments. The present paper
presents a spectrum of neurosurgical tools that have been
developed in the last two years.
Researchers at UC Berkeley have been working on devel-
oping a new brain injury detector that is cheap, easy to use,
and can provide nearly immediate results. This device sends
radio signals that pass through the brain and are detected
using a special antenna.The underlying technology is known
as “Volumetric Electromagnetic Phase Shift Spectroscopy
(VEPS)” and can detect changes in tissue properties inside the
body through noncontacting, multifrequency electromag-
netic measurements from the exterior of the body, thus pro-
viding rapid and inexpensive diagnostic testing (Figure 1)
[5, 6]. This is a diagnostic method for brain injury that can
be used in poor rural areas where the population has no
access to advancedmedical technology and services [5].Thus,
the patient will receive a rapid diagnosis, even from nonspe-
cialized personnel, and it can then be decided whether to
transfer him to advanced medical services for further neu-
romonitoring, which can be crucial for the outcome and the
quality of life of the patient. Only time will tell which of these
technological solutions will become commonly used in the
future to help diagnose brain trauma, and the VEPS headset
is only completing small trials at the moment, so it is still far
from reaching the rural communities it hopes to help. Still,
the innovation in this field shows that we may have improved
Figure 1: Brain injury detector based on Volumetric Electromag-
netic Phase Shift Spectroscopy. Courtesy of UC Berkeley.
Figure 2:The infrascanner intracranial haematoma detector, model
2000. Courtesy of Infrascan Handheld brain diagnostics.
treatments and diagnosis for traumatic brain injury not only
rapidly but also well ahead of time [7, 8].
The updated infrascanner model 2000 intracranial
haematoma detector is another tool for the neurosurgeon
that has received FDA approval (Figure 2).This is a device for
detecting intracranial haematomas. It is meant to be a simple,
easy-to-use screening tool, which can be used to identify high
risk patients requiring further workup, including CT [9]. An
estimated, 1.5 million individuals seek medical treatment for
head trauma in the USA each year, and a total of 10 million
individuals seek head trauma treatment annually worldwide
[10–15]. Intracranial haematomas resulting from a traumatic
brain injury are life-threatening and have been reported to
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Figure 3: The Clotbust ER ultrasound system for thrombolysis.
Courtesy of Cerevest Therapeutics Inc.
occur as the primary injury in 40% of patients with severe
head injury [10–15]. Successful treatment often relies upon
timely diagnosis and intervention prior to neurological
deterioration. The early identification of a brain haematoma
can play a significant role in facilitating transportation of
critically injured patients to facilities which can verify
Infrascanner’s early diagnosis and offer surgical intervention.
“Before the Infrascanner, first responders had to rely on
imprecise methods to detect brain bleeds in patients,
potentially delaying treatment,” said Dr. Joseph Maroon,
Professor and Vice Chairman of the Department of
Neurological Surgery at the University of Pittsburgh, team
neurosurgeon for the Pittsburgh Steelers, and Medical
Advisory Board member of civilian Infrascanner distributor,
MedLogic, LLC. “Whether on the field of battle with military
medical personnel or on the thousands of playing fields
with sports health professionals in professional, amateur, or
youth sports, the Infrascanner can potentially save lives by
quickly detecting life-threatening brain bleeds earlier,” added
Dr. Maroon. It seems to be the frontier for the further
management of a potential patient with haematoma. This
instrument can be easily used by any physician and can
immediately demonstrate whether a haematoma is present
or not. The first physician at the scene of injury can then
decidewhether the patient should be immediately transferred
to an advanced medical centre to be treated and monitored.
There is always the possibility of false positive results, which
can be considered as minor faults, since the haematoma
patients will be diagnosed immediately and the acute transfer
to a neurosurgical department would be beneficial for the
patient. This device uses near-infrared technology to detect
intracranial bleeding. Extravascular blood absorbs near-
infrared light more than intravascular blood, due to the
higher concentrations of haemoglobin in an acute haemat-
oma compared to brain tissue. The scanner measures the
difference in near-infrared absorption and provides a simple
signal that indicates whether bleeding is likely to be present
[9, 16].
The Clotbust ER is another important ultrasound system
that has received the CE mark and that is potentially an
important tool for the emergency department (Figure 3).This
Figure 4: The Fore-sight monitor for cerebral blood flow in stroke
treatment. Courtesy of Casmed, Brandord, CT, USA.
is an ultrasound system from Cerevest Therapeutics, Inc.,
and is a sonolysis system used to treat ischaemic stroke in
emergency settings. The Clotbust ER is designed to deliver
therapeutic ultrasound energy noninvasively to occluded
blood vessels in the brain, together with standard intravenous
thrombolytic therapy. The energy of the ultrasound beam is
transformed into energy of fluid motion. At very low pres-
sures, this streaming inside the brain causes mild stirring,
leading to the exposure of additional fibrin sites to plasmin.
Integrated software controls the delivery of consistent thera-
peutic levels of energy required to attain acoustic streaming,
which makes the device operator-independent and it avoids
the need for an experienced ultrasound specialist [17–19].
Some clinical studies have suggested that when ultrasound
energy is applied during conventional intravenous tPA
thrombolysis, the process of clot lysis is augmented, allowing
more rapid resolution of blood flow to the ischaemic brain.
This process is termed sonothrombolysis. The hope is that in
the future, IV thrombolysis may be superseded by the use of
cavitating microspheres in conjunction with sonothrombol-
ysis, which may hopefully enhance clot dissolution further.
The small size of these spheres (1.2 microns) allows them to
penetrate and pass through the fibrinmatrix of the blood clot
[20, 21].
This seems to be an essential tool for the physician in the
emergency department. With this tool, the physician (even
when he is not a specialist) can noninvasively deliver ultra-
sound energy to a patient who has just been diagnosed with
an ischaemic stroke in the ER.The thrombus starts to dissolve
and can be then treated with a standard intravenous throm-
bolytic agent. That is extremely important, since this can
provide a better outcome and better quality of life for the
patient with ischemic stroke, without the need for specialised
personnel.
For stroke treatment and monitoring in the emergency
department, attentionmust be drawn to the new device called
Fore-sight from Casmed of Branford, CT, USA (Figure 4)
[22]. A clinical evaluation led by Dr. DavidMacLeod at Duke
University Medical Center in Durham, NC, USA, examined
the relationship of cerebral tissue oxygen saturation (SctO2)
measured by fore-sight to longer termpostoperative cognitive
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Figure 5: The “Presto” Cranial blood flow monitor. Courtesy of
Physiosonics.
decline 6 weeks after surgery. New clinical study results
show that casmed’s fore-sight technology provides superior
accuracy and potential for improved outcomes. Decreased
forebrain cerebral tissue oxygen saturation is associated with
cognitive decline after cardiac surgery [22]. Subjects were
given a battery of cognitive tests, both before and 6weeks after
surgery, for verbal memory and language comprehension,
figure memory, attention and concentration, and psychomo-
tor and processing speed. This observational study showed
that decreased intraoperative SctO2 levels are potentially
associated with longer term forebrain postoperative cognitive
decline. It is believed that this was the first study to provide
initial evidence that longer term postoperative cognitive
decline may be associated with decreased cerebral tissue
oxygen saturation measured by cerebral oximetry [23]. This
device measures blood oxygen in a similar manner to a
finger clip pulse oximeter. Continuous near-infrared regional
cerebral perfusion monitoring is provided in stroke patients.
The sensors stick on like adhesive bandages above each
of the patient’s eyebrows and emit near-infrared light that
penetrates the scalp and underlying brain tissue [24]. As with
Clotbust, this device is easily used by nonspecialist physi-
cians. The application of a simple sensor sticker provides
essential information for the management of a stroke patient.
Another tool of significant importance for the neurosur-
geon specialist in emergencies is the Presto, which monitors
cranial blood flow without a sonographer (Figure 5). This is
a device that has received FDA clearance and it allows any
clinician to perform cranial blood flowmonitoring without a
professional sonographer. The system features proprietary
autolocating technology that allows users to easily locate and
keep the ultrasound beam focused on the cerebral artery [25].
ThePresto 1000 FlowMonitor will helpwith ICU and surgical
patients, by detecting abnormal changes in cerebral blood
Figure 6:The “HeadSense” intracranial pressure monitor. Courtesy
of HeadSense Company.
flow and alerting the attending nurse, bringing further insti-
tutional resources to diagnose the cause. These flow anoma-
liesmay be indicators of severe conditions, such as vasospasm
from aneurysm ruptures or head trauma, disturbances in
brain autoregulation or MCA blood clots [26]. Taking into
account its function, and user-friendliness, this can be really
considered as a vital device for neurosurgical emergencies.
Without the specific knowledge of a sonographer, even a
junior registrar can measure cranial blood flow and rather
rapidly provide crucial information to the specialist. This
ensures that appropriate treatment is rapidly provided and
may even save the patient’s life.
An essential device for emergencies in neurological
surgery is the HeadSense intracranial pressure monitor
(Figure 6). In this device, the ear buds may help avoid having
to drill into the skull. Elevated transcranial pressure from
an injury or disease is a dangerous condition that can be
life-threatening, painful, and debilitating. Because our thick
skulls do not allow traditional external pressure monitoring,
invasive methods that penetrate the skull have been used.
This is why intracranial pressure monitoring continues to be
rooted in the 20th century. With simple ear buds, even a
nonspecialist junior physician can easily decide whether the
patient’s intracranial pressure needs conservative or surgical
treatment. This decision can be crucial for the patient’s life,
as well as for economic health management. HeadSense,
a company from Netanya, Israel, has been working on a
noninvasive monitor that sends and detects sound waves to
measure intracranial pressure. It looks like a generic mp3
player but, instead of playingmusic, the ear bud plays tones of
different frequencies and measures how they sound from the
other side of the head. ABluetooth-enabled tablet receives the
data from the HeadSense device and analyses it to provide a
final output of the pressure [27].
Furthermore, the portable full body CT scanner—
BodyTom—has been awarded the CE mark and is another
important device for the emergency department (Figure 7).
This is a battery powered tomograph and can be transported
to the patient from room to room, allowing it to be used in
places such as the clinic, the ICU, and the emergency depart-
ment. The specifications of the scanner itself include a 32
slice CT with a 85 cm gantry and 60 cm view [28]. The
BodyTom is the latest development inNeuroLogica’s portable
computed tomography imaging line. The battery powered
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Figure 7: The “Bodytom” portable full body CT scanner. Courtesy
of Neurologica.
BodyTom can be transported from room to room and is
compatible with PACS, surgical navigation, electronic med-
ical records, and planning systems. Its unique capabilities
provide high quality CT images wherever needed, including
the Clinic, ICU, operation room, and Emergency/Trauma
Department. The combination of rapid scan time, flexible
settings, and immediate image viewing makes the BodyTom
a valuable tool to any facility needing versatile real-time CT
imaging [29].
By providing real-time updates as the surgery unfolds,
the scanner eliminates the need to move patients between
operating room and radiology suite and makes surgery safer.
BodyTom can obtain images of the entire spine in one pass,
providing detailed three-dimensional images of both bone
and soft tissue that is unavailable using the flat-panel fluo-
roscopic imaging that is typically found in most operating
suites. This enables the surgeon to assess any developing
complications before the patient leaves the operating room
[30].
The importance of this device is (more than) obvious. You
donot have to be a specialist to support its usefulness in emer-
gencies. With this portable CT scanner, you can always have
immediate neuromonitoring, even in the smallest medical
centres. Moreover, the scanner is cost-effective, as it can be
used by all the departments of the institute, especially if we
are dealing with a small capacity medical centre.
Remaining with the theme of diagnostic testing and
computed tomography monitoring, the IMRIS CT (Figure 8)
should be mentioned. IMRIS Inc. (IMRIS) designs, manu-
factures, and markets the VISIUS Surgical Theatre, a multi-
functional surgical environment that provides intraoperative
vision to clinicians. Designed to fulfil a hospital’s clinical
needs, the VISIUS SurgicalTheatre can incorporatemagnetic
Figure 8:The ceiling-mounted intraoperative “VISIUS iCT”. Cour-
tesy of IMRIS Company.
resonance (MR) imaging, computed tomography (CT) imag-
ing, and X-ray angiography in a number of configurations,
providing intraoperative images of diagnostic quality. IMRIS
sells the VISIUS Surgical Theatres globally to hospitals that
deliver clinical services to patients in the neurosurgical,
cerebrovascular, and cardiovascular markets. The VISIUS
Surgical Theatre incorporates magnetic resonance imaging,
CT, and fluoroscopy into multipurpose surgical suites to
provide truly intraoperative imaging for specific medical
applications [31].
The FDA has given clearance to IMRIS for its ceiling-
mounted intraoperative CT system, the VISIUS iCT. This is
the world’s first and only such system that rides on a ceiling-
mounted track and can be deployed around the patientwithin
30 seconds when necessary. Because the system does not
touch the ground, there are many fewer things to keep in
mind when deploying the scanner, and the operation can be
resumed quickly once the scan is done [27]. It is obviously
an extraordinary device. It saves time for the treatment of the
neurosurgical patient in the operation theatre of the emer-
gency department. However, this is an extremely specialist-
oriented machine and its use can only be focused in special
medical centres. It cannot be considered as the frontier tool
for neurosurgical emergencies, but may be regarded as an
essential device in reference neurosurgical centres. State-
of-the-art CT imaging is then accessed effortlessly in the
operation room (OR).
Developed for cranial and spinal neurosurgery, VISIUS
iCT is a specialized multifunctional surgical theatre that
brings state-of-the-art image quality directly to patients in the
OR. The first and only ceiling-mounted intraoperative CT
travels on-demand to the patient—without introducing addi-
tional risks by moving the patient or having anything touch
the floor—and preserves the OR protocols, including optimal
surgical access and techniques [32].
VISIUS iCT is a state-of-the-art surgical theatre that
provides personalized dose management together with diag-
nostic quality imaging during the surgical procedure, in order
to assist surgeons in critical decision-making. The 64-slice
scanner effortlessly moves into and out of the operating
room during surgery, using ceiling-mounted rails to ease
workflow.This enables multiple room configurations to meet
both clinical requirements and increased utilization without
compromising image quality or exam speed.
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Figure 9: The Artis angiography system, courtesy of Siemens
Company.
Patient transport and the need for the floor-mounted rails
used in other systems are eliminated, opening up valuableOR
space and allowing unimpeded movement of surgical equip-
ment and simplified infection control. The system also offers
the longest scanner travel range on the market today.
In addition, VISIUS iCT features a suite of software appli-
cations, such as 3D volume rendering, in order to aid surgical
planning and dose reduction. This considers each patient’s
unique characteristics and needs to maximize image quality
and minimize dose. “State-of-the-art dose management is
one of the keys to driving the adoption of iCT to guide
surgical procedures,” Graves said.
The system software allows healthcare practitioners to
visualize dosage prior to scan and adjust settings based on the
specific clinical need, with detailed dosage reports produced
after each scan [33].
Finally, another new device that would be a great assis-
tance to the specialist in the ED is the new angiography
system from Siemens (Artis Q, Artis Q. zen), which has
been awarded FDA approval (Figure 9). The device features
the latest X-ray tubes and detectors, which together deliver
the highest quality imaging and are capable of spotting tiny
vessels in the brain and heart during interventional proce-
dures.The system also features low radiation dosemodes that
allow imaging at lower quality when the best imaging is
unnecessary [16]. This new angiography system though is
also—as IMRIS CT—a device that cannot be used as frontline
tool for neurosurgical emergencies. It must be used by
specialists. Nevertheless, the features of the new angiography
system make it an important implement for the structure of
a developed neurosurgical centre, to improve the quality of
patient treatment.The new imaging component techSiemens
Artis Qnology is touted by Siemens as a “revolutionary new
X-ray tube and detector technology” that will improve image
quality and fine detail resolution, all with a dose level that is
lower than the traditional tube and detector technology
presently being used. The X-ray tube from Siemens now uti-
lizes flat emitter technology rather than the traditional coiled
filament technology.This is now coupled with the new detec-
tor design that utilizes crystalline silicon rather than amor-
phous silicon as the detector material. Siemens claims that
the new design provides a more homogenous design with
better signal amplification, while at the same time reducing
the noise at ultralow dose settings. Thus, it provides better
images at lower power and doses.
Siemens claims that the new combination of tube and
detector provides visibility of small vessels at a rate that is 70%
higher than with the previous generation technology. If this
is proven to be clinically valid in everyday use, the promise of
better resolution at lower power and lower dose levels will be
a significant step, as interventional procedures become more
and more complex with longer times. This may translate into
the potential for extended exposure to radiation during the
procedure [34].
In addition to the hardware innovations, there are several
new software applications.The Artis Q and Q. zen will be the
first angiography systems to feature IVUS map, integrating
intravascular ultrasound (IVUS) with angiographic images.
With the simultaneous views of the vessels’ interior wall via
IVUS with precise location on the angioimage, IVUS map
efficiently supports physicians in diagnostic testing and stent
placement. CLEARstent Live enhances the visibility of stents
in real time during therapy whilst simultaneously stabilising
the image, resulting in a clear image of the intervention
without time lag. Other new 3D applications, such as syngo
DynaCT micro, provide substantial improvements in spatial
resolution, by enhancing the smallest details in crucial areas
such as imaging of intracranial stents or other miniscule
structures, such as the cochlea in the inner ear. Organs such
as the lungs can be imaged in 3D in less than three seconds
with syngo DynaCT Highspeed, reducing the number of
motion artefacts and the amount of contrast agent required.
For oncological procedures, personalised therapy is the key
to improve the access to the disease and to improve patient
outcomes. A new 3D functional imaging protocol, syngo
DynaPBVBody, shows blood distribution bymeans of colour
coded cross-sectional blood volume maps, along with quan-
titative measurement of blood volume in lesions, in order to
assess changes in perfusion over the course of treatment [35].
4. Ethics
The last twenty years have been the rise of neuroscience,
molecular biology, and brain imaging technologies, which
have changed our understanding of the human brain. Neu-
roscientists are currently working on the development of
an array of therapeutic cognitive enhancements for humans.
These technologies are in the pioneering stage and promise
further insights into our understanding of the brain. Some
scientists consider that the twenty first century will be to
neuroscience as the twentieth century was to physics [36].
The sheer size of the brain’s neural network, comprising
approximately 100 billion neurons and over 100 trillion
synaptic connections, will represent an enormous challenge
for NBIC in the future. Fantasies about mind control will
remain elusive, since science has yet to determine how
the brain encodes memory and more fundamentally how
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mind works [37]. Developments in BMIs, for example, will
probably comprise two phases; the current phase consists of
therapeutically based BMIs for disabled persons and in the
second phase, BMIs will be developed to enhance cognitive
andmotor skills in healthy humans [37].McGee andMaguire
(2001) also predict a third phase in BMI development, which
will involve the use of neural devices for information transfer
capability [38]. While this phase is still a long way off, it does
indicate future possibilities for BMI once the technology is
developed.
Episodes of neurosurgical care are associated with the
expenditure of huge health system resources and have tre-
mendous impact on quality of life and clinical outcomes,
disproportionate to the size of our specialty and to the num-
ber of individual encounters. The complex medical, social,
and ethical dimensions of these interventions preclude sub-
stituting mid-level providers, such as physician assistants
and nurse practitioners, for the neurosurgeon. Many neu-
rosurgical care episodes are concentrated at the extremes of
age (i.e., at the beginning and end of life), focus on an unfor-
giving nervous system, and/or require continuous subspe-
cialty coverage for stroke, hydrocephalus, and neurotrauma,
and thus have tremendous impact on both healthcare and
health system outcomes. For these reasons, neurosurgical
practitioners have passionately embraced the modern era of
medical education, training, and innovation as a method of
improving the outcomes of our patients and for advancing
our specialty. Neurosurgery has emerged as a leader and
innovator, and is therefore an area of medical practice that
should be targeted for additional support and enhanced
attention to educational best practices, rather than cuts in
economic support [39].
5. Discussion
ICT will no longer mean only intracranial tension. It will
signify an even more important term—“Information and
Communication Technology”. Distance today has become
meaningless and geography has become history. Advances
in medical technology and surgical techniques have dramat-
ically improved diagnosis and treatment of most disorders,
saving and extending lives. Yet the technology revolution
has to bypass certain difficulties for urgent medical care in
different hospital establishments. Tomorrow’s neurosurgeon
will be part of digital health, digital hospitals, EMR, HIS,
telemedicine, telemonitoring, and mHealth. With a mini
iPad or equivalent low cost tablet, he/she will be able to
work with anyone, anytime, anywhere. Professor Google and
Dr. Facebook will ensure that the patient is truly empow-
ered, with real time access to almost the same exabytes of
information as the neurosurgeon. “Caveat emptor”—let the
buyer beware—the neurosurgeon of 2020 could very well be
on the receiving end [40]. Ultimately, aligning preclinical
and clinical standards on a large scale, as well as the vast
use of modern technology healthcare tools in emergency
neurosurgery, has the potential to greatly impact the lives
of patients waiting for new treatments for brain and spinal
cord injury in A & E Departments worldwide. In the 50 years
since computed tomography was introduced to everyday
medical use, the importance of new diagnostic technologies
has become increasingly crucial. The pressure on physicians
to be quick, effective, and to avoid any misjudgement of
the patient has been transferred to our technology. Neuro-
surgery is obviously faced with many new opportunities and
challenges, based on advanced technological approaches and
molecular approaches to neurosurgical problems. Advances
in technology have allowed the neurosurgeon to precisely
locate abnormal tissue in the brain and spinal cord, thereby
preserving normal tissues from surgical trauma. However, it
is far from easy to predict the future role of the neurosurgeon.
It is doubtful whether important turns and unexpected nov-
elties can be foreseen by people of today, who are anchored
to the palpable realities and submitted to all kinds of current
limitations. Exposure to fantasies and wishful thinking will
easily lead to errors and misunderstandings. Prophecies of
this kind will be impregnated by current limitations. The
reality is that a neurosurgeon will continually feel the force of
the development and the need for new technology that will
provide our patients with better outcomes and quality of life.
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